Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 3/2014

01.09.2014 | Maternal-Fetal Medicine

Assessment of endothelial function in pregnant women with preeclampsia and gestational diabetes mellitus by flow-mediated dilation of brachial artery

verfasst von: Maria Fernanda Brandão de Resende Guimarães, Augusto Henriques Fulgêncio Brandão, Cezar Alencar de Lima Rezende, Antônio Carlos Vieira Cabral, Ana Paula Brum, Henrique Vitor Leite, Carolina Andrade Bragança Capuruço

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To compare endothelial function, as assessed by flow-mediated dilation (FMD) in pregnant women with preeclampsia (PE), gestational diabetes mellitus (GDM) and healthy pregnant women.

Methods

We conducted a cross-sectional study of eighty women who were selected and divided into three groups: Group A comprising 42 pregnant women with PE, Group B (control) consisting of 19 normotensive pregnant women with no comorbidities and Group C consisting of 19 pregnant women with GDM. The women underwent FMD and the results were compared between groups. The data were obtained from the Center for Fetal Medicine, Hospital das Clínicas, Federal University of Minas Gerais, Brazil (CEMEFE-HC-UFMG) after approval by the Ethics and Research Committee on June 4, 2008 under no CAAE-0280.0.203.000-08.

Results

Nonparametric variance analysis showed no statistically significant difference between the characteristics of the three groups. The comparison between the results of the mean values of brachial artery FMD groups of pregnant women with preeclampsia (FMD = 5.36 ± 4.61 %), gestational diabetes (FMD = 9,18 ± 5.98 %) and pregnant women in the control group (FMD = 17.55 ± 8.35 %) showed that a statistically significant difference was found between groups using the Dunn test. The comparison between groups PE × GDM was not statistically significant. The group consisting of pregnant women with GDM associated with those with PE had significantly lower results for FMD (6.55 ± 5.33 %) than the control group (17.55 ± 8.35 %, p = 0.00).

Conclusions

The group consisting of pregnant women with GDM or PE showed results for FMD significantly lower than the control group, suggesting possible endothelial injury in these patients.
Literatur
1.
Zurück zum Zitat World Health Organization (2005) The World health report: make every mother and child count. World Health Organization, Geneva World Health Organization (2005) The World health report: make every mother and child count. World Health Organization, Geneva
2.
Zurück zum Zitat Callow AD (1999) Endothelial dysfunction in atherosclerosis. In: Catravas JD, Callow AD, Ryan US (eds) Vascular endothelium: mechanisms of cell signaling. IOS Press, Knossos, pp 81–88 Callow AD (1999) Endothelial dysfunction in atherosclerosis. In: Catravas JD, Callow AD, Ryan US (eds) Vascular endothelium: mechanisms of cell signaling. IOS Press, Knossos, pp 81–88
3.
Zurück zum Zitat Cudihy D, Lee RV (2009) The pathophysiology of pré-ecalmpsia: current clinical concepts. J Obstet Gynaecol 29:576–582PubMedCrossRef Cudihy D, Lee RV (2009) The pathophysiology of pré-ecalmpsia: current clinical concepts. J Obstet Gynaecol 29:576–582PubMedCrossRef
4.
Zurück zum Zitat De Vriese AS, Verbeuren TJ, Voorde JVV, Lameire NH, Vanhoutte PM (2000) Endothelial dysfunction in diabetes. Br J Pharmacol 130:963–974PubMedCentralPubMed De Vriese AS, Verbeuren TJ, Voorde JVV, Lameire NH, Vanhoutte PM (2000) Endothelial dysfunction in diabetes. Br J Pharmacol 130:963–974PubMedCentralPubMed
5.
Zurück zum Zitat Young BC, Levine RJ, Karumanchi SA (2010) Pathogenesis of preeclampsia. Annu Rev Pathol 5:173–192PubMedCrossRef Young BC, Levine RJ, Karumanchi SA (2010) Pathogenesis of preeclampsia. Annu Rev Pathol 5:173–192PubMedCrossRef
6.
Zurück zum Zitat Savvidou MD, Lut Geerts L, Nicolaides KH (2002) Impaired vascular reactivity in pregnant women with insulin-dependent diabetes mellitus. Am J Obstet Gynecol 186:84–88PubMedCrossRef Savvidou MD, Lut Geerts L, Nicolaides KH (2002) Impaired vascular reactivity in pregnant women with insulin-dependent diabetes mellitus. Am J Obstet Gynecol 186:84–88PubMedCrossRef
7.
Zurück zum Zitat Frijns CJ, Kappelle LJ, van Gijn J, Nieuwenhuis HK, Sixma JJ, Fijnheer R (1997) Soluble adhesion molecules reflect endothelial cell activation in ischemic stroke and in carotid atherosclerosis. Stroke 28:2214–2218PubMedCrossRef Frijns CJ, Kappelle LJ, van Gijn J, Nieuwenhuis HK, Sixma JJ, Fijnheer R (1997) Soluble adhesion molecules reflect endothelial cell activation in ischemic stroke and in carotid atherosclerosis. Stroke 28:2214–2218PubMedCrossRef
8.
9.
Zurück zum Zitat Quyyumi AA (1998) Endothelial function in health and disease: new insights into the genesis of cardiovascular disease. Am J Med 105:32S–339SPubMedCrossRef Quyyumi AA (1998) Endothelial function in health and disease: new insights into the genesis of cardiovascular disease. Am J Med 105:32S–339SPubMedCrossRef
10.
Zurück zum Zitat Puddu P, Puddu GM, Zaca F, Muscari A (2000) Endothelial dysfunction in hypertension. Acta Cardiol 55:221–232PubMedCrossRef Puddu P, Puddu GM, Zaca F, Muscari A (2000) Endothelial dysfunction in hypertension. Acta Cardiol 55:221–232PubMedCrossRef
11.
Zurück zum Zitat Cohen RA (1995) The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease. Prog Cardiovasc Dis 38:105–128PubMedCrossRef Cohen RA (1995) The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease. Prog Cardiovasc Dis 38:105–128PubMedCrossRef
12.
13.
Zurück zum Zitat Wedel JC, Mandala M, Barron C, Bernstein I, Osol G (2009) Mechanisms underlying maternal venous adaptation in pregnancy. Reprod Sci 16:596–604CrossRef Wedel JC, Mandala M, Barron C, Bernstein I, Osol G (2009) Mechanisms underlying maternal venous adaptation in pregnancy. Reprod Sci 16:596–604CrossRef
14.
Zurück zum Zitat Luksha L, Nisell H, Kublickiene K (2004) The mechanism of EDHF-mediated responses in subcutaneous small arteries from healthy pregnant women. Am J Physiol Regul Integr Comp Physiol 286:1102–1109 Luksha L, Nisell H, Kublickiene K (2004) The mechanism of EDHF-mediated responses in subcutaneous small arteries from healthy pregnant women. Am J Physiol Regul Integr Comp Physiol 286:1102–1109
15.
Zurück zum Zitat Gillham JC, Kenny LC, Baker PN (2003) An overview of endothelium-derived hyperpolarising factor (EDHF) in normal and compromised pregnancies. Eur J Obstet Gynecol Reprod Biol 109:2–7PubMedCrossRef Gillham JC, Kenny LC, Baker PN (2003) An overview of endothelium-derived hyperpolarising factor (EDHF) in normal and compromised pregnancies. Eur J Obstet Gynecol Reprod Biol 109:2–7PubMedCrossRef
16.
Zurück zum Zitat Yinon Y, Kingdom JC, Odutayo A, Moineddin R, Drewlo S, Lai V, Cherney D, Hladunewich M (2010) Vascular dysfunction in women with a history of preeclampsia and intrauterine growth restriction: insights into future vascular risk. Circulation 122:1846–1853PubMedCrossRef Yinon Y, Kingdom JC, Odutayo A, Moineddin R, Drewlo S, Lai V, Cherney D, Hladunewich M (2010) Vascular dysfunction in women with a history of preeclampsia and intrauterine growth restriction: insights into future vascular risk. Circulation 122:1846–1853PubMedCrossRef
17.
Zurück zum Zitat Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S et al (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111:649–658PubMedCentralPubMedCrossRef Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S et al (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111:649–658PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat Gilbert JS, Ryan MJ, LaMarca BB, Sedeek M, Murphy SR, Granger JP (2008) Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol 294:H541–H550PubMed Gilbert JS, Ryan MJ, LaMarca BB, Sedeek M, Murphy SR, Granger JP (2008) Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol 294:H541–H550PubMed
19.
Zurück zum Zitat Report of the National High Blood Pressure Education (2000) Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol 183:S1–S22CrossRef Report of the National High Blood Pressure Education (2000) Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol 183:S1–S22CrossRef
20.
Zurück zum Zitat World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. WHO, Geneva World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. WHO, Geneva
21.
Zurück zum Zitat Dørup I, Skajaa K, Sørensen KE (1999) Normal pregnancy is associated with enhanced endothelium-dependent flow-mediated vasodilation. Am J Physiol 276:H821–H825PubMed Dørup I, Skajaa K, Sørensen KE (1999) Normal pregnancy is associated with enhanced endothelium-dependent flow-mediated vasodilation. Am J Physiol 276:H821–H825PubMed
22.
Zurück zum Zitat Quinton AE, Cook CM, Peek MJ (2007) A longitudinal study using ultrasound to assess flow-mediated dilatation in normal human pregnancy. Hypertens Pregnancy 26:273–281PubMedCrossRef Quinton AE, Cook CM, Peek MJ (2007) A longitudinal study using ultrasound to assess flow-mediated dilatation in normal human pregnancy. Hypertens Pregnancy 26:273–281PubMedCrossRef
23.
Zurück zum Zitat Yoshida A, Nakao S, Kobayashi M, Kobayashi H (2000) Flow-mediated vasodilation and plasma fibronectin levels in preeclampsia. Hypertension 36:400–404PubMedCrossRef Yoshida A, Nakao S, Kobayashi M, Kobayashi H (2000) Flow-mediated vasodilation and plasma fibronectin levels in preeclampsia. Hypertension 36:400–404PubMedCrossRef
24.
Zurück zum Zitat Brandão AH, Cabral MA, Leite HV, Cabral AC (2012) Endothelial function, uterine perfusion and central flow in pregnancies complicated by preeclampsia. Arq Bras Cardiol 99(4):931–935PubMedCrossRef Brandão AH, Cabral MA, Leite HV, Cabral AC (2012) Endothelial function, uterine perfusion and central flow in pregnancies complicated by preeclampsia. Arq Bras Cardiol 99(4):931–935PubMedCrossRef
25.
Zurück zum Zitat Savvidou MD, Hingorani AD, Tsikas D, Frolich JC, Vallance P, Nicolaides KH (2003) Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop preeclampsia. Lancet 361:1511–1517PubMedCrossRef Savvidou MD, Hingorani AD, Tsikas D, Frolich JC, Vallance P, Nicolaides KH (2003) Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop preeclampsia. Lancet 361:1511–1517PubMedCrossRef
26.
Zurück zum Zitat García RG, Celedón J, Sierra-Laguado J, Alarcón MA, Luengas C, Silva F et al (2007) Raised C-reactive protein and impaired flow-mediated vasodilation precede the development of preeclampsia. Am J Hypertens 20:98–103PubMedCrossRef García RG, Celedón J, Sierra-Laguado J, Alarcón MA, Luengas C, Silva F et al (2007) Raised C-reactive protein and impaired flow-mediated vasodilation precede the development of preeclampsia. Am J Hypertens 20:98–103PubMedCrossRef
27.
Zurück zum Zitat Pàez O, Alfie J, Gorosito M, Puleio P, de Maria M, Prieto N et al (2009) Parallel decrease in arterial distensibility and in endothelium-dependent dilatation in young women with a history of preeclampsia. Clin Exp Hypertens 31:544–552PubMedCrossRef Pàez O, Alfie J, Gorosito M, Puleio P, de Maria M, Prieto N et al (2009) Parallel decrease in arterial distensibility and in endothelium-dependent dilatation in young women with a history of preeclampsia. Clin Exp Hypertens 31:544–552PubMedCrossRef
28.
Zurück zum Zitat Stehouwer CDA, Lambert J, Donker AJM, Van Hinsbergh VWM (1997) Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 34:55–68PubMedCrossRef Stehouwer CDA, Lambert J, Donker AJM, Van Hinsbergh VWM (1997) Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 34:55–68PubMedCrossRef
29.
Zurück zum Zitat Anastasiou E, Lekakis JP, Alevizaki M, Papamichael CM, Megas J (1998) Impaired endothelium-dependent vasodilatation in women with previous gestational diabetes. Diabetes Care 21:2111–2115PubMedCrossRef Anastasiou E, Lekakis JP, Alevizaki M, Papamichael CM, Megas J (1998) Impaired endothelium-dependent vasodilatation in women with previous gestational diabetes. Diabetes Care 21:2111–2115PubMedCrossRef
30.
Zurück zum Zitat Stanley JL, Sankaralingam S, Baker PN, Davidge ST (2010) Previous gestational diabetes impairs long-term endothelial function in a mouse model of complicated pregnancy. Am J Physiol Regul Integr Comp Physiol 299:R862–R870PubMed Stanley JL, Sankaralingam S, Baker PN, Davidge ST (2010) Previous gestational diabetes impairs long-term endothelial function in a mouse model of complicated pregnancy. Am J Physiol Regul Integr Comp Physiol 299:R862–R870PubMed
31.
Zurück zum Zitat Dollberg S, Brockman DE, Myatt L (1997) Nitric oxide synthase activity in umbilical and placental vascular tissue of gestational diabetic pregnancies. Gynecol Obstet Invest 44:177–181PubMedCrossRef Dollberg S, Brockman DE, Myatt L (1997) Nitric oxide synthase activity in umbilical and placental vascular tissue of gestational diabetic pregnancies. Gynecol Obstet Invest 44:177–181PubMedCrossRef
32.
Zurück zum Zitat Calver AJ, Collier J, Vallance P (1992) Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 90:2548–2554PubMedCentralPubMedCrossRef Calver AJ, Collier J, Vallance P (1992) Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 90:2548–2554PubMedCentralPubMedCrossRef
33.
Zurück zum Zitat Westermeier F, Puebla C, Veja JL, Farías M, Escudero C, Casanello P, Sobrevia L (2009) Equilibrative nucleoside transporters in fetal endothelial dysfunction in diabetes mellitus and hyperglycaemia. Curr Vasc Pharmacol 7:435–449PubMedCrossRef Westermeier F, Puebla C, Veja JL, Farías M, Escudero C, Casanello P, Sobrevia L (2009) Equilibrative nucleoside transporters in fetal endothelial dysfunction in diabetes mellitus and hyperglycaemia. Curr Vasc Pharmacol 7:435–449PubMedCrossRef
Metadaten
Titel
Assessment of endothelial function in pregnant women with preeclampsia and gestational diabetes mellitus by flow-mediated dilation of brachial artery
verfasst von
Maria Fernanda Brandão de Resende Guimarães
Augusto Henriques Fulgêncio Brandão
Cezar Alencar de Lima Rezende
Antônio Carlos Vieira Cabral
Ana Paula Brum
Henrique Vitor Leite
Carolina Andrade Bragança Capuruço
Publikationsdatum
01.09.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 3/2014
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-014-3220-x

Weitere Artikel der Ausgabe 3/2014

Archives of Gynecology and Obstetrics 3/2014 Zur Ausgabe

Gynecologic Endocrinology and Reproductive Medicine

Does endometrial injury improve implantation of frozen–thawed embryos?

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.